News

Small cap round-up: China Eastsea, May Gurney, Angel Biotechnology...

02 October 2008 10:41:00

Software group China Eastsea has blamed the Olympic Games for subdued trading during the six months ended August with results below management expectations.

Contract negotiations with local government bodies and other companies have taken longer to complete, it says, though August itself was better. "The company has a strong order book going forward and although it is too early to determine the outcome for the full financial year, the directors expect to see a solid second half," it added.

Construction services group May Gurney's first half to September has been in line with expectations. "Local Authority spending in our sectors remains robust with good bidding prospects, and despite the short term volatility related to the rebidding processes in Utility services, the regulatory commitment to these areas makes us confident about the outlook," it said. The secured and framework forward order book is now worth £1.25bn, it added.

Biopharma contract manufacturer Angel Biotechnology has met all the criteria necessary to fully comply with storage and processing standards currently required by the Human Tissue Authority. Angel is now fully compliant to manufacture those treatments which fall outside the Medicines and Healthcare products Regulatory Agency's (MHRA) remit.

"We believe ability to manufacture HTA-regulated therapies will strengthen our current client relationships and present many new business opportunities to Angel," said Gordon Sherriff, chief operating officer.

Business communications provider Alternative Networks said trading and cash generation for the year to September remained robust, in line with management expectations.

"The group ended the year with a strong performance in Q4, seeing good momentum in terms of new business signed and significant progress made across most metrics, particularly in Mobile and Fixed Networks Services, even when measured against the strong start to the financial year," it said.

It added that it is confident of its growth prospects as it moves into the next financial year.

Surface engineering technology provider Hardide said overall trading for the year to September has been in line with market expectations and it remains positive on the outlook for the future.

Orders are returning to previous levels, following the unexpected reduction in demand from a major UK customer, it said.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.